Stay updated on Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial
Sign up to get notified when there's something new on the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page.

Latest updates to the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page
- Check5 days agoChange DetectedThe clinical study record is no longer displayed and the page shows a 403 Forbidden message. An NIH website transition notice is also shown.SummaryDifference18%

- Check12 days agoChange DetectedThe record now displays details for the completed eteplirsen study, including its objectives, treatment plan, eligibility criteria, outcomes, and study locations. It also includes publication and study-history information.SummaryDifference45%

- Check19 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.0 to v3.7.1 while the study page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check33 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study content with an access-denied message. The prior study details and related navigation are no longer visible on this page.SummaryDifference17%

- Check40 days agoChange DetectedA new page revision identifier 'Revision: v3.7.0' has been added. The previous revision 'Revision: v3.6.6' has been removed, reflecting an update to the page's versioning.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page's Revision value changed from v3.6.5 to v3.6.6. This indicates a minor update to the page without altering the displayed study details.SummaryDifference0.1%

Stay in the know with updates to Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page.